Palisade Bio Potential Upside
| PALI Stock | | | USD 1.99 -0.01 -0.50% |
Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument. Below is Palisade Bio's current Potential Upside with peer comparisons and related risk metrics.
Current Potential Upside Value
Palisade Bio registers a Potential Upside of 10.34, reflecting moderate estimated upside from current levels. Palisade Bio trades below the model-derived fair value estimate by a meaningful margin.
Potential Upside | = | 1PM2PM |
| = | 10.34 | |
| 1PM | = | First upper moment |
| 2PM | = | Second upper moment |
Potential Upside Peers Comparison
Palisade Bio falls below the 10.55 peer average for Potential Upside. Athira Pharma leads at 16.18 while Briacell Therapeutics Corp registers the lowest at 5.37. Palisade Bio shows less estimated upside from current levels than the peer average.
Potential Upside Relative To Other Indicators
The chart below plots Potential Upside against Maximum Drawdown for Palisade Bio and its peers. Each point represents one equity — position along the horizontal axis shows Potential Upside while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
At
10.34 for Potential Upside and
30.02 for Maximum Drawdown, Palisade Bio's cross-indicator ratio sits almost
2.90 . This indicates Maximum Drawdown is significantly higher than Potential Upside for Palisade Bio.
Methodology, Assumptions & Data Sources
Palisade Bio has a current Potential Upside reading of 10.34. Palisade Bio's Potential Upside is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. Values are specific to the selected time horizon and may differ across measurement periods. This indicator does not constitute investment advice.
Other Technical Indicators